HJLI specializes in developing and manufacturing bioprosthetic medical devices to establish improved standards of care for treating cardiac and vascular diseases. HJLI currently has two product candidates: the porcine tissue based VenoValveÂŽ, which is intended to be surgically implanted in the deep venous system of the leg to treat Chronic Venue Insufficiency and the CoreoGraftÂŽ, a bovine tissue based off the shelf conduit intended to be used for coronary artery bypass surgery.
Source
